IL6 and breast carcinoma: For instance, interleukin-6 (IL-6) is sufficient for converting non-CSCs to CSCs in different breast cells [30], and IL-6 regulates the conversion of non-CSCs into CSCs [31], activating the Notch-3-dependent upregulation of the Notch ligand Jagged-1 in breast cancer cells [32].